Evaluating joint effects of induction-salvage treatment regimes on overall survival in acute leukaemia

Journal of the Royal Statistical Society. Series C: Applied Statistics

Volumn 62, Issue 1, 2013, Pages 67-83

  Wahed, Abdus S ^a   Thall, Peter F ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Causal inference; Clinical trial; Dynamic treatment regime; Treatment policy

Indexed keywords

EID: 84871253928     PISSN: 00359254     EISSN: 14679876     Source Type: Journal    
DOI: 10.1111/j.1467-9876.2012.01048.x     Document Type: Article

References (24)

1. Estey, E. H., Shen, Y. and Thall, P. F. (2000) Effect of time to complete remission on subsequent survival and disease-free survival in AML, RAEB-t, and RAEB. Blood, 95, 72-77.
2. Estey, E. H., Thall, P. F., Pierce, S., Cortes, J., Beran, M., Kantarjian, H., Keating, M. J., Andreeff, M. and Freireich, E. (1999) Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin ± granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome. Blood, 93, 2478-2484.
3. Estey, E. H., Thall, P. F., Pierce, S., Kantarjian, H. and Keating, M. (1997) T treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. J. Clin. Oncol., 15, 483-490.
4. Holland, P. (1986) Statistics and causal inference. J. Am. Statist. Ass., 81, 945-960.
5. Lavori, P. W. and Dawson, R. (2000) A design for testing clinical strategies: biased adaptive within-subject randomization. J. R. Statist. Soc. A, 163, 29-38.
6. Lavori, P. and Dawson, R. (2004) Dynamic treatment regimes: practical design considerations. Clin. Trials, 1, 9-20.
7. Lunceford, J., Davidian, M. and Tsiatis, A. A. (2002) Estimation of the survival distribution of treatment policies in two-stage randomization designs in clinical trials. Biometrics, 58, 48-57.
8. Murphy, S. A. (2003) Optimal dynamic treatment regimes (with discussion). J. R. Statist. Soc. B, 65, 331-366.
9. Murphy, S. A. (2005) An experimental design for the development of adaptive treatment strategies. Statist. Med., 24, 1455-1481.
10. Murphy, S. A., van der Laan, M., Robins, J. M. and CPPRG (2001) Marginal mean models for dynamic treatment regimes. J. Am. Statist. Ass., 96, 1410-1424.
11. Robins, J. M. (1986) A new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy survivor effect. Math. Modlng, 7, 1393-1512.
12. Robins, J. M. (1997) Causal inference from complex longitudinal data latent variable modeling and applications to causality. Lect. Notes Statist., 120, 69-117.
13. Robins, J. M. (2004) Optimal structural nested models for optimal sequential decisions. In Proc. 2nd Seattle Symp. Biostatistics (eds D. Y. Lin and P. Heagerty ). New York: Springer
14. Robins, J. M., Hernan, M. A. and Brumback, B. (2000) Marginal structural models and causal inference in epidemiology. Epidemiology, 11, 550-560.
15. Robins, J. M., Orellana, L., Hernan, M. and Rotnitzky, A. (2008) Estimation and extrapolation of optimal treatment and testing strategies. Statist. Med., to be published.
16. Robins, J. M. and Rotnitzky, A. (1992) Recovery of information and adjustment for dependent censoring using surrogate markers. In AIDS Epidemiology, Methodological Issues (eds N. Jewell, K. Dietz and V. Farewellpp. 297-331. Boston: Birkhäuser.
17. Schwarz, G. (1978) Estimating the dimension of a model. Ann. Statist., 6, 461-464.
18. Shen, Y. and Thall, P. F. (1998) Parametric likelihoods for multiple non-fatal competing risks and death. Statist. Med., 17, 999-1016.
19. Thall, P. F., Logothetis, C., Pagliaro, L., Wen, S., Brown, M. A., Williams, D. and Millikan, R. (2007) Adaptive therapy for androgen independent prostate cancer: a randomized selection trial including four regimens. J. Natn. Cancer Inst., 99, 1613-1622.
20. Thall, P. F., Millikan, R. and Sung, H. G. (2000) Evaluating multiple treatment courses in clinical trials. Statist. Med., 19, 1011-1028.
21. Thall, P. F., Sung, H.-G. and Estey, E. H. (2002) Selecting therapeutic strategies based on efficacy and death in multi-course clinical trials. J. Am. Statist. Ass., 97, 29-39.
22. Wahed, A. S. and Tsiatis, A. A. (2004) Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics, 60, 124-133.
23. Wahed, A. S. and Tsiatis, A. A. (2006) Semiparametric efficient estimation of survival distribution for treatment policies in two-stage randomization designs in clinical trials with censored data. Biometrika, 93, 163-177.
24. Zhao, Y., Kosorok, M. R. and Zeng, D. (2009) Reinforcement learning design for cancer clinical trials. Statist. Med., 28, 3294-3315.